DiaSorin S.p.A. (BIT:DIA)
Italy flag Italy · Delayed Price · Currency is EUR
90.50
-0.42 (-0.46%)
Jul 25, 2025, 5:35 PM CET

DiaSorin Company Description

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally.

It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name.

The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens.

In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay.

Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

DiaSorin S.p.A.
DiaSorin logo
CountryItaly
Founded1968
IndustryDiagnostics & Research
SectorHealthcare
Employees3,308
CEOCarlo Rosa

Contact Details

Address:
Via Crescentino snc
Saluggia, Vercelli 13040
Italy
Phone39 016 1487526
Websiteint.diasorin.com

Stock Details

Ticker SymbolDIA
ExchangeBorsa Italiana
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberIT0003492391
SIC Code2835

Key Executives

NamePosition
Carlo RosaChief Executive Officer, GM and Executive Director
Dr. Chen Menachem EvenChief Commercial Officer, Senior Corporate Vice President of Commercial Operations and Executive Director
Piergiorgio PedronSenior Corporate Vice President, Chief Financial Officer and Corporate Accounting Documents Officer
Dr. Riccardo FavaCorporate Vice President of Communication, ESG and Investor Relations
Ulisse SpadaCorporate Vice President, Head of the Legal Department, Secretary and General Counsel
Amelia ParenteSenior Corporate Vice President of Human Resources
Angelo RagoPresident of Luminex Corporation